VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 10/31/2022 | 10/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.90K | 45.50K | 3.00K | 24.10K | 24.10K |
| Total Receivables | 60.00K | 130.00K | 230.00K | 2.02M | 2.02M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.40K | 12.60K | 15.70K | 5.60K | 5.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 14.70K | -- | -- |
| Total Current Assets | 106.30K | 188.10K | 263.40K | 2.05M | 2.05M |
|
|
|||||
| Total Current Assets | 106.30K | 188.10K | 263.40K | 2.05M | 2.05M |
| Net Property, Plant & Equipment | 171.00K | 216.80K | 261.50K | 375.70K | 375.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 23.60K | 17.60K | 17.60K |
| Total Assets | 277.30K | 404.90K | 548.50K | 2.44M | 2.44M |
|
|
|||||
| Total Accounts Payable | 2.73M | 2.62M | 2.50M | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 138.30K | 182.10K | 175.80K | 45.90K | 45.90K |
| Total Finance Division Other Current Liabilities | 577.60K | 577.60K | 486.30K | 427.70K | 427.70K |
| Total Other Current Liabilities | 577.60K | 577.60K | 486.30K | 427.70K | 427.70K |
| Total Current Liabilities | 3.44M | 3.38M | 3.16M | 473.60K | 473.60K |
|
|
|||||
| Total Current Liabilities | 3.44M | 3.38M | 3.16M | 473.60K | 473.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 47.20K | 283.70K | 283.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 4.50K | 4.50K |
| Total Liabilities | 3.44M | 3.38M | 3.21M | 761.80K | 761.80K |
|
|
|||||
| Common Stock & APIC | 1.12M | 1.07M | 1.03M | 920.30K | 920.30K |
| Retained Earnings | -4.28M | -4.05M | -3.69M | 811.00K | 811.00K |
| Treasury Stock & Other | -- | -- | -- | -50.00K | -50.00K |
| Total Common Equity | -3.17M | -2.97M | -2.66M | 1.68M | 1.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.17M | -2.97M | -2.66M | 1.68M | 1.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.17M | -2.97M | -2.66M | 1.68M | 1.68M |
|
|
|||||